Viral polymerase complex (VPC)

Viral polymerase complexes are essential multi-protein assemblies responsible for the replication and transcription of viral genomes within host cells (Source: NIH, 2023). These complexes, such as the RNA-dependent RNA polymerase (RdRp) found in RNA viruses or DNA polymerases in DNA viruses, are critical for the viral life cycle as they catalyze the synthesis of new viral nucleic acids (Source: UniProt, 2024). Because these enzymes often lack direct human homologs or possess distinct structural features, they serve as highly effective targets for antiviral therapy (Source: Nature Reviews Drug Discovery, 2021). Drugs targeting these complexes typically function as nucleoside analogs that induce premature chain termination or as non-nucleoside inhibitors that bind to allosteric sites to disrupt enzymatic activity (Source: StatPearls, 2023). For instance, in influenza, the heterotrimeric polymerase complex (PA, PB1, and PB2) is targeted by inhibitors like Baloxavir marboxil, which blocks the cap-snatching mechanism required for viral mRNA synthesis (Source: FDA, 2018). In the context of global health, targeting these complexes has been pivotal in treating chronic infections like Hepatitis C and emerging threats like SARS-CoV-2 (Source: WHO, 2022).

Other names

RNA-dependent RNA polymerase complexRdRp complexViral replicase complexViral transcription complexDNA-directed DNA polymerase complexViral RNA polymeraseViral DNA polymerase

Inhibition of viral nucleic acid synthesis through mechanisms including obligate or non-obligate chain termination, competitive inhibition with natural nucleosides, and inhibition of the cap-snatching endonuclease activity within the complex.